glp 1 receptor agonists and dpp 4 inhibitors Role of DPP-4 in Clinical Practice Cardiovascular effects of the DPP-4
Description
doi: 10.1016/S2213-8587(18)30104-9 43 KohanDEPollockDM
S/02/24 and SRF-HF/24)
What are the key, highly anticipated readouts in ongoing obesity and cardiovascular outcomes trials
Liu L, Chen J, Wang C, Chen L, Chen L
Simultaneously, it suppresses glucagon secretion from pancreatic alpha cells, reducing hepatic glucose production
